Last edition
News about "Freelite Assays "
Thermo Fisher Scientific Gets Extended 510k Clearance of Freelite Assays for Evaluation of MGUS
Thermo Fisher Scientific Inc. has received 510k clearance, following US Food and Drug Administration (FDA) requirements, to market its Optilite Freelite assays’ claim for the evaluation of monoclonal gammopathy of undetermined significance (MGUS).
Freelite Assays | 30/07/2024 | By Aishwarya | 188
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members